ATNM (STOCKS)
Actinium Pharmaceuticals, Inc
$1.120000
-0.020000 (-1.75%)
Prev close: $1.140000
Company Information
- Exchange
- XASE
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Sandesh Seth
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $34.94M
- Employees
- 31
- P/E (TTM)
- -1.03
- P/B (TTM)
- 2.58
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $90.00K |
| Nonoperating Income/Loss | $2.74M |
| Operating Expenses | $37.43M |
| Research and Development | $21.64M |
| Other Operating Expenses | $15.59M |
| Operating Income/Loss | -$37.34M |
| Income/Loss From Continuing Operations After Tax | -$34.60M |
| Income/Loss From Continuing Operations Before Tax | -$29.38M |
| Net Income/Loss | -$34.60M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$34.60M |
| Net Income/Loss Available To Common Stockholders, Basic | -$34.60M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.11 |
| Diluted Earnings Per Share | -$1.10 |
| Basic Average Shares | 62,769,809 |
| Diluted Average Shares | 31,573,918 |
| Assets | $56.15M |
| Current Assets | $54.37M |
| Noncurrent Assets | $1.79M |
| Fixed Assets | $226.00K |
| Other Non-current Assets | $1.56M |
| Liabilities | $42.37M |
| Current Liabilities | $6.83M |
| Noncurrent Liabilities | $35.53M |
| Equity | $13.78M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $13.78M |
| Liabilities And Equity | $56.15M |
| Net Cash Flow From Operating Activities | -$25.04M |
| Net Cash Flow From Operating Activities, Continuing | -$25.04M |
| Net Cash Flow From Investing Activities | $19.51M |
| Net Cash Flow From Investing Activities, Continuing | $19.51M |
| Net Cash Flow From Financing Activities | -$217.00K |
| Net Cash Flow From Financing Activities, Continuing | -$217.00K |
| Net Cash Flow | -$5.75M |
| Net Cash Flow, Continuing | -$5.75M |
| Comprehensive Income/Loss | -$34.60M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$34.60M |
| Other Comprehensive Income/Loss | $0.00 |